Acquisition by Affidea of IHZD AG in Eastern Switzerland

Affidea Group, the pan-European provider of specialist healthcare services, including cancer care, advanced diagnostic imaging and community-based polyclinics, pursues its expansion in Switzerland by acquiring a majority stake of Institut für histologische und zytologische Diagnostik AG (IHZD) operating from Aarau and Zurich.

This acquisition adds two high-quality pathology laboratories close to Affidea’s Centre of Excellence in Breast Cancer, Brust-Zentrum Zurich. With the addition of histopathology, molecular pathology, and cytology diagnostics, Affidea Switzerland now provides a fully integrated and seamless cancer care pathway, covering prevention, early detection, genetic testing, precise diagnosis, personalised treatment, and post-treatment support.

Chabrier supported Affidea Group in all legal aspects of the transaction. The Chabrier team was led by Thomas Goossens, Partner, together with Manuel Bianchi della Porta, Partner, as well as Daima Vuilleumier, Counsel, Thierry Burnens, Counsel, and Karina Santa Rita, Associate. This transaction was also a great opportunity to showcase the expertise of Chabrier’s legal professionals operating from our brand new Zurich office.

Read more